Article
Adaptive and Innate Immunity Are Key Drivers of Age at Onset of Multiple Sclerosis
29 May 2024
Abstract excerpt
Background and Objectives: Multiple sclerosis (MS) age at onset (AAO) is a clinical predictor of long-term disease outcomes, independent of disease duration. Little is known about the genetic and biological mechanisms underlying age of first symptoms. We conducted a genome-wide association study (GWAS) to investigate associations between individual genetic variation and the MS AAO phenotype. Methods: single...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
